Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 87,002 | 72,974 | 66,120 | 61,493 | 50,138 |
| Cost of Goods | 14,519 | 13,894 | 12,423 | 11,319 | 11,058 |
| Gross Profit | 72,483 | 59,080 | 53,697 | 50,174 | 39,080 |
| Operating Expenses | 67,990 | 65,445 | 59,778 | 60,133 | 60,295 |
| Operating Income | 5,012 | -5,471 | -5,658 | -9,640 | -21,157 |
| Interest Expense | 270 | 14 | 2 | 2 | 3 |
| Other Income | 3,144 | 2,996 | 3,119 | 2,769 | 2,399 |
| Pre-tax Income | 7,886 | -2,489 | -2,541 | -6,873 | -18,761 |
| Income Tax | -1,034 | 45 | 39 | 32 | 16 |
| Net Income Continuous | 8,920 | -2,534 | -2,580 | -6,905 | -18,777 |
| Net Income | $8,920 | $-2,534 | $-2,580 | $-6,905 | $-18,777 |
| EPS Basic Total Ops | 0.32 | -0.09 | -0.08 | -0.26 | -0.70 |
| EPS Basic Continuous Ops | 0.32 | -0.09 | -0.09 | -0.26 | -0.70 |
| EPS Diluted Total Ops | 0.31 | -0.09 | -0.08 | -0.26 | -0.70 |
| EPS Diluted Continuous Ops | 0.31 | -0.09 | -0.09 | -0.26 | -0.70 |
| EPS Diluted Before Non-Recurring Items | 0.31 | -0.09 | -0.10 | N/A | N/A |
| EBITDA(a) | $6,637 | $-3,830 | $-4,074 | $-8,035 | $-19,170 |